Committee Opinion No. 479: Methamphetamine abuse in women of reproductive age.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 21343793.
- Also identified by DOI 10.1097/AOG.0b013e318214784e.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Methamphetamine abuse has continued to increase in the United States since the late 1980s with its use spreading from the West Coast to areas across the country. Methamphetamine use in pregnancy endangers the health of the woman and increases the risk of low birth weight and small for gestational age babies and such use may increase the risk of neurodevelopmental problems in children. All pregnant women should be asked about their drug and alcohol use. Urine toxicology screening may be useful in detecting methamphetamine and other substance abuse during pregnancy, but this screening should only be done with maternal consent after counseling regarding the potential ramifications of a positive test result. Women reporting continuing use of methamphetamine in pregnancy should be referred for treatment and followed up with serial ultrasound examinations to assess fetal growth.
Medical subject headings
- Amphetamine-Related Disorders
- Central Nervous System Stimulants
- Maternal Exposure
- Methamphetamine
- Prenatal Exposure Delayed Effects